Article info

other Versions

PDF
Are molecular scanners going to make double-blind placebo-controlled trials impossible?

Authors

  1. Correspondence to Professor Konstantinos N Fountoulakis, 3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki 54636, Greece; kfount{at}med.auth.gr
View Full Text

Citation

Fountoulakis KN
Are molecular scanners going to make double-blind placebo-controlled trials impossible?

Publication history

  • Received August 23, 2016
  • Accepted August 31, 2016
  • First published September 16, 2016.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.